John L. Warden, Jr.

John L. Warden, Jr. is the Co-Founder & CEO at HeMemics Biotechnologies. John has entrepreneurial and executive roles in 5 start-up companies to date, returning more than $75M in net profits to investors. He has successful business development experience with Biovista, a drug development services provider to major pharmaceutical companies, significant impact building markets for technology products, and developed, engineered, and constructed the proprietary software and hardware for the HEMEMICS chip and the reader device.